Used as a key intermediate in pharmaceutical synthesis, particularly in the preparation of kinase inhibitors for cancer treatment. Its boron-containing structure enables Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds in drug development. Commonly employed in the synthesis of bioactive molecules and targeted therapies due to its stability and reactivity in palladium-catalyzed reactions. Also utilized in medicinal chemistry research for constructing pyridine-based scaffolds with potential neurological and oncological activity.